Aged-rodent models of long-term growth hormone therapy: Lack of deleterious effect on longevity

Dike N. Kalu, Paul B. Orhii, Cang Chen, Doug Yoon Lee, Gene B. Hubbard, Shuko Lee, Yemi Olatunji-Bello

Research output: Contribution to journalArticlepeer-review

25 Scopus citations

Abstract

Studies were carried out to examine the effects of long-term recombinant human growth hormone (GH) therapy on longevity in rodents. In the first study, 150 18-month-old female F344 rats were divided into three groups of 50 rats per group: Group 1, solvent vehicle; Group 2, 10 μg GH/kg body weight three times per week; Group 3, 50 μg GH/kg body weight three times per week. GH and solvent vehicle therapies were started at 18 months of age and continued until all the animals died spontaneously. Serum insulin-like growth factor (IGF)-I was measured at 18 and 29 months of age and on 3-month-old rats. Serum IGF-I level decreased between 3 and 29 months of age. GH therapy reversed the decrease in a dose-dependent manner, with the 50 μg GH dose returning the serum IGF-I level to that of 3-month-old animals. However, statistical analysis revealed no significant effect of GH therapy on median life span, loth percentile life span, or maximum life span. Similar observations on longevity were made on aged F344 male rats and on aged Balb/c mice, even when the dose of GH was increased to 1.0 mg/kg body weight two times per week. The main pathologic lesions in control animals were nephropathy, cardiomyopathy, leukemia, and testicular interstitial cell tumor; the prevalence of these lesions was not significantly altered by GH therapy. We conclude that long-term low-dose GH therapy that includes doses in the range that is given to humans in clinical trials in GH deficiency and to revert age-related physiologic declines has no overt deleterious effects on longevity and pathology in aged rodents.

Original languageEnglish (US)
Pages (from-to)B452-B463
JournalJournals of Gerontology - Series A Biological Sciences and Medical Sciences
Volume53
Issue number6
DOIs
StatePublished - 1998
Externally publishedYes

ASJC Scopus subject areas

  • Aging
  • Geriatrics and Gerontology

Fingerprint Dive into the research topics of 'Aged-rodent models of long-term growth hormone therapy: Lack of deleterious effect on longevity'. Together they form a unique fingerprint.

Cite this